CatalystPit

ODTXOdyssey Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $22.22 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$1.07B
CountryUSA
RECENT INSIDER TRADES
  • 2026-05-13 · TPG GP A, LLC (Other) · OTHER
  • 2026-05-13 · TPG GP A, LLC (Other) · BUY
  • 2026-05-12 · Dimension Capital II, L.P. (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders58
Shares held34,815,124
Value$642.58M
Percent of shares outstanding72.48%
As of quarter end2026-06-30
RECENT NEWS
  • Odyssey Therapeutics to present phase 2a trial design for UC
  • Raymond James initiates Odyssey Therapeutics stock coverage with outperform rating
  • Odyssey Therapeutics at Stifel forum: pipeline bets and cash runway
  • Odyssey Therapeutics presents at Morgan Stanley healthcare conference
  • Odyssey Therapeutics to participate in Stifel 2026 Virtual Immunology Forum
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Odyssey Therapeutics, Inc. (ODTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit